Submitted by Anonymous (not verified) on 26 March 2026 - 11:28
Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 28, Status: Authorised
Source: